Pisgah Labs, Inc. Tackles Prescription Drug Abuse As It Files Eighth Patent

PISGAH FOREST, N.C., Jan. 12, 2010 — According to the Office of National Drug Control Policy (http://www.whitehousedrugpolicy.gov), prescription drug abuse is more prevalent than abuse of cocaine, heroin and methamphetamine. In fact, in the past year, prescription drug abuse ranked second…

Slumps in Pharmaceutical Profitability Tied to Insufficient Management Training

DELTA POINT, Inc.’s 2009 Leadership Skills Survey reveals the crucial relationship between gaps in sales management training and poor sales performance

SCOTTSDALE, Ariz., Oct. 14, 2009 — When it comes to slumping profitability in the current pharmaceutical sales industry, it is easy t…

MyClinicalTrial.com Launch Provides Solution to Online Healthcare and Clinical Trial Information

Provides No-Charge Trial Listing Service for Investigator Sites, Sponsors, CROs

GLEN BURNIE, Md., Sept. 23, 2009 — Clinical Site Services (CSS), a leader in patient enrollment solutions for the clinical research industry, announces the launch of its comprehensive website, http://www.MyCl…

Author’s Unwelcome Sequel Brings Light to Addiction

Richard McKenzie Neal chronicles the repetition of his son’s seemingly endless addiction to heroin

FOUNTAIN VALLEY, Calif., Feb. 18, 2009 — “The Path to Addiction … ‘and other troubles we are born to know’” (published by AuthorHouse) is a sequel that Ric…

Next Safety Announces Bid Date for the Sale of the Company’s Platform for the Pulmonary Delivery of Albuterol and the Components of Advair(TM)

JEFFERSON, N.C., Dec. 22, 2008 — Next Safety has developed a proprietary platform that delivers nicotine and a number of other drugs including albuterol and the components of Advair(TM), fluticasone propionate and salmeterol xinofoate, in air timed to the user’s inhalation. Certain US…